Accenture (ACN) director Alan Jope granted 7 RSUs – Form 4

Accenture plc director Alan C. Jope reported a small equity award in the form of restricted share units.

Rhea-AI Filing Summary

Accenture plc director Alan C. Jope reported a small equity award in the form of restricted share units. On 11/14/2025, he received 7 Class A ordinary shares at a price of $0 per share, reflecting a grant of RSUs made under anti-dilution provisions tied to Accenture's cash dividend. These provisions are designed so that previously granted RSU awards are adjusted when the company pays a dividend, helping keep the economic value of the prior awards consistent. Following this adjustment, Jope beneficially owns 1,985 Class A ordinary shares directly.

Insider Trade Summary

Grant/Award: 7 shares

Grant/Award 1 txn

Insider Jope Alan C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	7	$0.00	$0.00

Holdings After Transaction: Class A ordinary shares — 1,985 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

FAQ

What did Accenture (ACN) director Alan C. Jope report on this Form 4?

Alan C. Jope reported receiving 7 Class A ordinary shares of Accenture plc via a grant of restricted share units (RSUs) on 11/14/2025, at a price of $0 per share.

Why were the 7 RSUs granted to Alan C. Jope at Accenture (ACN)?

The 7 RSUs were granted pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

How many Accenture (ACN) shares does Alan C. Jope own after this transaction?

Following the reported RSU-related share grant, Alan C. Jope beneficially owns 1,985 Class A ordinary shares of Accenture plc in direct ownership.

What type of security was involved in Alan C. Jope's Form 4 for Accenture (ACN)?

The filing reports Class A ordinary shares of Accenture plc, received through a grant of restricted share units (RSUs) rather than an open-market purchase.

Did Alan C. Jope pay anything for the 7 Accenture (ACN) shares reported?

No. The 7 Class A ordinary shares were acquired at a price of $0 per share, consistent with an RSU adjustment under anti-dilution terms.

Is this Accenture (ACN) Form 4 related to a Rule 10b5-1 trading plan?

The form includes a checkbox to indicate if a transaction is under a Rule 10b5-1(c) trading plan, but the excerpt does not show that this box was marked as selected.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jope Alan C.

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	11/14/2025		A		7(1)	A	$0	1,985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Alan C. Jope	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.